These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6829500)

  • 1. Humoral and cellular studies of eosinophils in reactive and myeloproliferative syndromes with marked eosinophilia.
    Crowley JP; Myers TJ
    Am J Clin Pathol; 1983 Mar; 79(3):301-5. PubMed ID: 6829500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human peripheral blood and pleural fluid eosinophils can be induced by immune complexes to release IgG immune complexes and aggregated IgE.
    Rossi GA; Sacco O; Morelli A; Benatti U; Ravazzoni C; Damiani G
    Chest; 1988 Nov; 94(5):1014-22. PubMed ID: 3180852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal and metabolic properties of human eosinophils.
    Mickenberg ID; Root RK; Wolff SM
    Blood; 1972 Jan; 39(1):67-80. PubMed ID: 4550469
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
    Heinisch IV; Bizer C; Volgger W; Simon HU
    J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monocellular myeloproliferative syndromes with histologic protagonist. Primary histiocytosis and mastocytosis as potential monoclonal myelopathies].
    Sánchez Fayos J; Prieto Pareja E; Román Barbero A; Calabuig Fenollar T; Outeiriño Hernanz J
    Rev Clin Esp; 1997 Jul; 197(7):512-7. PubMed ID: 9411550
    [No Abstract]   [Full Text] [Related]  

  • 6. Altered density, metabolism and surface receptors of eosinophils in eosinophilia.
    Winqvist I; Olofsson T; Olsson I; Persson AM; Hallberg T
    Immunology; 1982 Nov; 47(3):531-9. PubMed ID: 7129529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.
    Valent P
    Blood Rev; 2009 Jul; 23(4):157-65. PubMed ID: 19246139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia.
    Arefi M; Robledo C; Peñarrubia MJ; García de Coca A; Cordero M; Hernández-Rivas JM; García JL
    Eur J Haematol; 2014 Nov; 93(5):422-8. PubMed ID: 24813417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composition of immune complexes and their relation to plasma fibronectin in chronic myeloproliferative disorders.
    Baglin TP; Simpson AW; Price SM; Boughton BJ
    J Clin Pathol; 1987 Dec; 40(12):1468-71. PubMed ID: 3429676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic lung disease: immunological studies of blood and alveolar eosinophils.
    Prin L; Capron M; Gosset P; Wallaert B; Kusnierz JP; Bletry O; Tonnel AB; Capron A
    Clin Exp Immunol; 1986 Jan; 63(1):249-57. PubMed ID: 3955885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High synovial immunoglobulin E levels in eosinophilic synovitis.
    Padeh S; Laxer RM; Gleich GJ; Armstrong PF; Silverman ED
    J Pediatr; 1992 Sep; 121(3):417-9. PubMed ID: 1517920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levels of serum IgE and eosinophilic granulocytes in women with cancer of the uterine cervix].
    Janković D; Bernt T; Cepulić E
    Jugosl Ginekol Perinatol; 1985; 25(3-4):61-4. PubMed ID: 3834246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic myeloproliferative disorder in a horse.
    Morris DD; Bloom JC; Roby KA; Woods K; Tablin F
    J Am Vet Med Assoc; 1984 Nov; 185(9):993-6. PubMed ID: 6511643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to corticosteroids in the hypereosinophilic syndrome. Association with increased serum IgE levels.
    Bush RK; Geller M; Busse WW; Flaherty DK; Dickie HA
    Arch Intern Med; 1978 Aug; 138(8):1244-6. PubMed ID: 677979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An anti-human eosinophil monoclonal antibody AE500 that reacts only with granulocytes from hypereosinophilic patients].
    Ochiai K; Iwamoto I; Kimura A; Nakagawa N; Tomioka H; Yoshida S; Takahashi H; Yoshida A
    Arerugi; 1990 May; 39(5):459-64. PubMed ID: 2393351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reversible defect of platelet PDGF content in myeloproliferative disorders.
    Baglin TP; Price SM; Boughton BJ
    Br J Haematol; 1988 Aug; 69(4):483-6. PubMed ID: 3408684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and application of novel immunoassays for eosinophil granule major basic proteins to evaluate eosinophilia and myeloproliferative disorders.
    Squillace DL; Checkel JL; Tefferi A; Kita H; Gleich GJ
    J Immunol Methods; 2021 Jun; 493():113015. PubMed ID: 33689807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANTES and eotaxin enhance CD11b and CD18 expression on eosinophils from allergic patients with eosinophilia in the application of whole Blood flow cytometry analysis.
    Chiba T; Kamada Y; Saito N; Oyamada H; Ueki S; Kobayashi Y; Kayaba H; Chihara J
    Int Arch Allergy Immunol; 2005; 137 Suppl 1():12-6. PubMed ID: 15947479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
    Matucci A; Vultaggio A; Maggi E; Kasujee I
    Respir Res; 2018 Jun; 19(1):113. PubMed ID: 29879991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.